Khalifeh et al[11] diagnosed colistin-related AKI in 46.9% of 113 patients using the KDIGO criterion and found that low serum albumin levels and the simultaneous use of 2 or more nephrotoxic agents with colistin were risk factors for AKI. This evidence concerns the gene ALB and acute kidney injury.